China: Siemens unit in China bribery probe

A Chinese regulator investigated Siemens AG very last year about irrespective of whether the German group’s healthcare device and its dealers bribed hospitals to acquire high priced disposable products and solutions made use of in some of its clinical devices, a few men and women with expertise of the probe instructed Reuters.

The investigation follows a vast-reaching probe into the pharmaceutical business in China that final year noticed GlaxoSmithKline fined just about $500 million for bribing officials to thrust its drugs income.

China’s State Administration for Sector and Commerce accused Siemens and its dealers of possessing violated level of competition law by donating clinical products in return for agreements to completely get the chemical reagents desired to run the machines from Siemens, the folks claimed.

A senior spokesman for Siemens in Germany claimed he was “not mindful” of the investigation and declined to remark on particular queries about the investigation.

Full content: Reuters

Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.